Axogen Inc (AXGN) USD0.01

Sell:$16.01Buy:$16.90$0.24 (1.49%)

Prices delayed by at least 15 minutes
Sell:$16.01
Buy:$16.90
Change:$0.24 (1.49%)
Deal now
Prices delayed by at least 15 minutes
Sell:$16.01
Buy:$16.90
Change:$0.24 (1.49%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

Key people

Michael Donald Dale
President, Chief Executive Officer, Director
Nir Naor
Chief Financial Officer
Marc A. Began
Executive Vice President, General Counsel
Jens Schroeder Kemp
Chief Marketing Officer
Craig A. Swandal
Vice President - Operations
Jesse Bishop
Vice President - Regulatory Affairs
Erick Wayne Devinney
Vice President - Peripheral Nerve Science and Clinical Innovations
Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Paul G. Thomas
Independent Chairman of the Board
Amy A. Mcbride-Wendell
Lead Independent Director
William P. Burke
Independent Director
John H. Johnson
Independent Director
Alan M. Levine
Independent Director
Click to see more

Key facts

  • EPIC
    AXGN
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US05463X1063
  • Market cap
    $692.65m
  • Employees
    451
  • Shares in issue
    44.34m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.